Oral Immune-Related Adverse Events – Current Concepts and their Management
| Autor: | Mohamed Faizal Asan, Renita Lorina Castelino, Subhas G Babu, Kumuda Rao, Vaibhav Pandita |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Asia-Pacific Journal of Oncology Nursing, Vol 8, Iss 6, Pp 604-609 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2347-5625 2349-6673 |
| DOI: | 10.4103/apjon.apjon-2136 |
| Popis: | Recent advent of immune checkpoint inhibitors (ICIs) have made significant improvement in the treatment outcome of cancer patients. They are also known to increase the overall survival in many malignancies. They target key immune checkpoints, acting on the cytotoxic T-lymphocyte antigen-4, programmed death-1 (PD-1), and PD-1 ligand 1 pathways. ICIs are effective in cancer therapy, but also possess various adverse effects that are termed together as immune-related adverse events (irAEs). Information focusing only on the oral reactions of irAEs is scanty in the literature. Therefore, we performed a computerized database search in PubMed and Google Scholar to identify and collect data regarding the oral adverse effects of ICIs. The early recognition of oral irAEs and appropriative intervention may help in improving the quality of life in patients. This paper presents a brief review of oral irAEs and their management. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|